Continuing Medical Education for Physicians, and Physicians' Assistants and Continuing Education for Registered Nurses

This program is the culmination of many years of research by the study team to identify ways to increase participation in cancer clinical trials. With this training, our goal is to improve cancer care by helping primary care providers to understand the critical role they play in facilitating equitable access to care and clinical trials. Thank you for joining us on this journey.

Program Title

Preparing Patients for Cancer Treatment Decisions: The Critical Role of Primary Care Providers in Facilitating Equitable Access to Care and Clinical Trials

Target Audience:

Primary Care Physicians, Physician Assistants, & Nurse Practitioners

Learning Objectives:

  • Strengthen primary care providers' knowledge around disparities in cancer care and in clinical trials
  • Understand the importance of the primary care provider role in preparing patients for referral
  • Foster patient engagement in cancer care
  • Consider changes to your referral process

Presented By:

  • Raymond Malihot, MD, MPH, Cancer Specialist (oncologist), Radiation Oncologist, University of Florida College of Medicine, Department of Radiation Oncology
  • Ana Natalie-Pereira, MD, MPH, FACP, Division Director, General Internal Medicine, Associate Professor of Medicine, Rutgers New Jersey Medical School, Department of Medicine
  • Margo Michaels, MPH, Principal, Health Care Access & Action Consulting

Faculty

  • Carma Bylund, PhD, Professor and Associate Chair of Education, University of Florida College of Medicine, Department of Health Outcomes and Biomedical Informatics
  • Elisa Weiss, PhD, Senior Vice President, Education, Services, & Health Research, The Leukemia & Lymphoma Society National Office

CME accreditation statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and The Leukemia & Lymphoma Society. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CME credit statement

The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit&tm;. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME/CE date of release

07/01/2024

CME/CE termination date

04/30/2025

CE statement

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing. There are no fees for participating in or receiving credit for this CE activity. To be eligible to earn CE credit, you must complete the entire course, including the post-test and evaluation. Once you have completed the course, a certificate of completion will be emailed to you.

Commercial Support

Support for this program is provided by The Leukemia & Lymphoma Society (PHP9007-22), Amgen Inc., Bristol Myers Squibb, AbbVie Inc., and AstraZeneca Pharmaceuticals LP.

Financial Disclosures

In accordance with the ACCME and California Board of Registered Nursing standards, we are required to disclose the relevant financial relationships of all persons involved in the selection, development, and presentation of CME content. Persons who refuse or fail to disclose conflicts of interest are disqualified from participating in the CME activity. All relevant financial relationships listed have been mitigated.

The following speakers and planning committee members have an affiliation/financial interest in the following areas:

  • Elisa Weiss, PhD - Research Support: Amgen Inc.; Bristol Myers Squibb; AbbVie Inc; Astra Zeneca Pharmaceuticals; Kite, A Gilead Company

The following speakers and planning committee members have no relevant financial relationships to disclose:

  • Carma Bylund, PhD
  • Raymond Malihot, MD, MPH
  • Ana Natalie-Pereira, MD, MPH, FACP
  • Margo Michaels, MPH

For concerns or questions regarding CME or CE accreditation, please contact alyssacrowe@ufl.edu